NGM BIOPHARMACEUTICALS INC Annual Operating Margin in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Ngm Biopharmaceuticals Inc quarterly/annual Operating Margin history and growth rate from 2017 to 2023.
  • Ngm Biopharmaceuticals Inc Operating Margin for the quarter ending December 31, 2023 was -3.43K %, a 1041% decline year-over-year.
  • Ngm Biopharmaceuticals Inc annual Operating Margin for 2023 was -3.43K %, a 1041% decline from 2022.
  • Ngm Biopharmaceuticals Inc annual Operating Margin for 2022 was -300 %, a 93.9% decline from 2021.
  • Ngm Biopharmaceuticals Inc annual Operating Margin for 2021 was -155 %, a 30.4% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -3.43K -3.13K -1041% Jan 1, 2023 Dec 31, 2023
2022 -300 -145 -93.9% Jan 1, 2022 Dec 31, 2022
2021 -155 -36.1 -30.4% Jan 1, 2021 Dec 31, 2021
2020 -119 -71.2 -149% Jan 1, 2020 Dec 31, 2020
2019 -47.7 -43.7 -1100% Jan 1, 2019 Dec 31, 2019
2018 -3.97 +18.6 +82.4% Jan 1, 2018 Dec 31, 2018
2017 -22.6 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.